Fennec Pharmaceuticals (FENC) intends to engage in a non-brokered offering of its common shares in Canada, at a price of $7.50 per share, with certain of its existing institutional shareholders, for ...
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced the pricing of its underwritten ...
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that it intends to offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback